Major Laboratories and Clinical & Translational Neurosciences Incubator
Showing 1-5 of 5 Results
-
Weidong Cai
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioMy research program investigates the neurobiological basis of cognitive dysfunction across the lifespan, focusing on two critical populations: children with neurodevelopmental disorders (e.g., ADHD) and elders with neurodegenerative conditions (e.g., Parkinson’s disease). By employing a highly interdisciplinary approach that integrates cognitive science, advanced functional neuroimaging, and computational modeling, I aim to delineate the neurocognitive processes governing both typical and atypical brain development and aging. The ultimate goal is to advance our understanding of the factors contributing to cognitive deficits and translate these findings into improved diagnostic tools and precision treatment strategies.
-
Victor G. Carrión
John A. Turner Endowed Professor for Child and Adolescent Psychiatry
Current Research and Scholarly InterestsExamines the interplay between brain development and stress vulnerability via a multi-method approach that includes psychophysiology, neuroimaging, neuroendocrinology and phenomenology. Treatment development that focuses on individual and community-based interventions for stress related conditions in children and adolescents that experience traumatic stress.
-
John Coetzee
Social Science Research Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioJohn obtained his BA in Psychology from UC Berkeley, where he worked in a sleep and psychopathology lab. He then worked in a depression lab at UCSF before entering a PhD program at UCLA, where he conducted research on the relationship between language and thought under the guidance of Dr. Martin Monti. After completing his doctorate in Cognitive Neuroscience, he returned to the Bay Area where he currently is a postdoctoral researcher at the Palo Alto VA in the lab of Dr. Maheen Adamson, where he is developing new treatments for traumatic brain injury, and at Stanford in the Brain Stimulation Lab, where he is developing new treatments for depression. His current focus in both labs is on noninvasive neuromodulation.
